A 12-week, multicenter, open label study to evaluate the effectiveness and safety of donepezil hydrochloride (E2020) in subjects with mild to severe Alzheimer's disease residing in an assisted living facility
Phase of Trial: Phase IV
Latest Information Update: 29 Oct 2013
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Eisai Inc
- 02 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Apr 2009 Actual initiation date changed from Dec 2007 to Jan 2008 as reported by ClinicalTrials.gov.
- 18 Apr 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.